SCHEMBL13575451

SCHEMBL13575451

C[C@]1(C(=O)O)Cc2sc(-c3ccc(C(=O)N4CCOCC4)cc3)cc2[C@H]1C1C=CC=CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
HPGD P15428 6/20 0.36
AOC3 Q16853 2/20 0.35
CHEK1 O14757 1/20 0.35
ALDH1A1 P00352 4/20 0.35
HTT P42858 3/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
HRH3 Q9Y5N1 3/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
ADRA2C P18825 1/20 0.35
CHRM3 P20309 1/20 0.35
DRD4 P21917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10211129 0.87 MAPK13 (0.36) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL10212091 0.82 MAPK13 (0.43) MAPK13MAPK12MAPK11MAPK14CHEK1
SCHEMBL490432 0.80 HPGD (0.43) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL10169814 0.80 HPGD (0.43) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL490433 0.80 HPGD (0.43) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL10169821 0.76 RIPK1 (0.41) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL490240 0.76 RIPK1 (0.41) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL10211121 0.74 NR3C1 (0.44) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL13575466 0.70 MAPK13 (0.39) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL10332064 0.63 MKNK1 (0.65) MAPK13MAPK12MAPK11MAPK14HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009158380-A1 CYCLOPENTATHIOPHENE MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-KAPPA B ACTIVITY AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY (US) 2009-12-30 WO disclosed